Ayahuasca Facts
Psychedelic;
Description
Ayahuasca (also Yagé, Hoasca, Natem) is a psychoactive brew prepared from the vine Banisteriopsis caapi (Malpighiaceae) and a DMT-containing admixture plant, most commonly Psychotria viridis. The vine's beta-carboline alkaloids block MAO-A — the enzyme that otherwise destroys oral DMT in the gut before it can reach the brain.[1] With MAO-A blocked, DMT reaches the brain and activates serotonin receptors, producing the psychedelic state.[2]
Subjective effects include vivid visual imagery, emotional catharsis, ego dissolution, intense introspection, and prominent nausea.[3] The experience lasts 4–8 hours and is shaped as much by brew composition, setting, and psychological readiness as by dose — analyzed preparations vary 280-fold in DMT concentration.[4]
Ayahuasca produces no physical dependence and no withdrawal; observational data suggest it may reduce rather than promote addictive behavior.[5] The dominant danger is the MAO-A inhibition window: combining ayahuasca with antidepressants or other serotonergic drugs can trigger serotonin syndrome — a potentially fatal response involving overheating, rigid muscles, and seizures.[6]
Dose and duration
No dose or duration recorded for any route.
Body and dependence
- Acute toxicity
- Low
- Chronic toxicity
- Negligible
- Physical dependence
- None
- Psychological dependence
- Negligible
- Withdrawal
- None recorded
- Compulsive redosing
- Negligible
Tolerance
- Builds
- None
- Fully resets after
- Not recorded
- Carries over to
- psilocybin;
LSD; mescaline
Effectslikely at a common dose
- Perception
- Visual drifting;
Tracers; Color alteration; Symmetrical texture repetition; Color enhancement; Geometry; Holotropic state; Visual breathing; Visual morphing; +25 possible, including Spatial disorientation, Visual haze / noise, Vestibular distortion - Body
- Nausea;
Pupil dilation; Wakefulness; Body scan awareness; Dizziness; +34 possible, including Vomiting, Motor control impairment, Excessive sweating - Thinking
- Pattern recognition enhancement;
Conceptual thinking; Immersion enhancement; Thought connectivity; Increased nature relatedness; Introspection enhancement; Openness enhancement; +28 possible, including Suggestibility enhancement, Cognitive impairment, Thought disorganization - Feeling
- Catharsis;
Emotional enhancement; Emotional lability; +7 possible, including Anxiety, Dysphoria, Paranoia - Self
- none likely · 12 possible, including Depersonalization, Derealization, Communication suppression
- Time
- Time alteration;
Temporal disorientation; +3 possible - Transpersonal
- Unity and interconnectedness
- Awareness
- Personal insight;
+4 possible
Who shouldn't take it
Combinations60 recorded
Seek help immediately if
Most difficulty is psychological (intense fear, panic, confusion) and passes with calm support — the signs below mean seek emergency help:
- Very high body temperature; hot, dry skin
- Seizures
- Chest pain; fast or irregular heartbeat
- Severe muscle rigidity, tremor, or twitching (possible serotonin syndrome)
- Cold, pale, or blue fingers/toes — severe vasoconstriction (notably NBOMe / DOx)
- Persistent vomiting; unconsciousness; uncontrollable agitation or risk of self-harm
What to do
- Stay calm and reassure — remind them they took a drug and the effect will pass
- Move to a calm, quiet, safe space with low light; reduce noise and sensory input
- Keep them from harm — they may act on fear or confusion; stay with them, don't leave them alone
- Talk them down gently; don't grab or restrain unless they're in danger
- For the medical signs above (overheating, seizure, chest pain, vasoconstriction, unresponsive) call emergency services
- If overheating, cool the body; be ready to give rescue breaths / CPR
The experience is time-limited and usually resolves with calm reassurance in a safe setting — psychological first aid, not medication. Serious physical harm is uncommon for classic psychedelics (LSD, psilocybin) but real for some potent phenethylamines (NBOMe, DOx), where hyperthermia, seizures, and vasoconstriction warrant emergency care.
988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE
References
- [1]^McKenna DJ, Towers GH, Abbott F (1984) Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca — Journal of Ethnopharmacology PMID:6587171
- [2]^Valle M, Maqueda AE, Rabella M et al. (2016) Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans — European Neuropsychopharmacology doi:10.1016/j.euroneuro.2016.03.012
- [3]^Politi M, Tresca G, Menghini L, Ferrante C (2022) Beyond the Psychoactive Effects of Ayahuasca: Cultural and Pharmacological Relevance of Its Emetic and Purging Properties — Planta Medica doi:10.1055/a-1675-3840
- [4]^Callaway JC (2005) Various alkaloid profiles in decoctions of Banisteriopsis caapi — Journal of Psychoactive Drugs PMID:16149328
- [5]^Nunes AA, Dos Santos RG, Osório FL, Sanches RF, Crippa JA, Hallak JE (2016) Effects of Ayahuasca and its Alkaloids on Drug Dependence: A Systematic Literature Review of Quantitative Studies in Animals and Humans — Journal of psychoactive drugs doi:10.1080/02791072.2016.1188225
- [6]^Ribeiro GSG, Paranhos BAPB, Dörr F, et al. (2026) Predicting drug-drug interactions between ayahuasca alkaloids and SSRIs using physiologically based pharmacokinetic modeling — Frontiers in Molecular Biosciences doi:10.3389/fmolb.2026.1768402